Effect and mechanism of hypotension by subcutaneous injection of ephedrine and local anesthetics in caesarean

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15007356

Enrollment

Unknown

Registered

2015-10-24

Start date

2015-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

caesarean

Interventions

Ephedrine group:Ephedrine

Control group:no

Eligibility

Sex/Gender

Female

Age

22 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I-II; 2. Preoperative Hb>110g/L, Hct>30%; 3. No arrhythmia, cardiac shunt and valvular heart disease, no hypertension; 4. No mental illness, and the cognitive ability is normal; 5. No serious liver and kidney disease; 6. No peripheral vascular disease.

Exclusion criteria

Exclusion criteria: 1. intraoperative blood loss was more than 800ml; 2. to a certain kind of narcotic drug allergies need to change the drug; 3. hemodynamic fluctuations in the operation; 4. cases of malignant hyperthermia; 5. other factors that affect patient safety.

Design outcomes

Primary

Measure	Time frame
MAP;HR;Ephedrine;	—

Countries

China

Contacts

Public ContactZhao Tao

feishi_xin@126.com+86 18863378768

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026